Phio Pharmaceuticals Corp.
PHIO· Nasdaq
Released Mar 22, 2023, after the close
10-K filed Mar 22, 2023, 81 days after period end · 0001683168-23-001678
derived · Computed from the longer spans the company filed.
| Metric | Q4 2022dderived from reported figures | Q4 2021dderived from reported figures | Q4 2020dderived from reported figures | Q4 2019dderived from reported figures |
|---|---|---|---|---|
| Revenue | — | — | $0.00 | $0.00 |
| Net Income | -$2.73M |
Phio Pharmaceuticals Corp. · CIK 1533040 · Engraved from SEC EDGAR
| -$3.45M |
| -$2.46M |
| -$2.66M |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.